Bill Ackman

Page 17 of 18

Pershing Square's Bill Ackman and Valeant Pharmaceuticals International's Michael Pearson Interview
Finance

The FBI is looking into possible Herbalife stock manipulation

By
March 13, 2015
Inside The South By Southwest (SXSW) Interactive Festival
Features

FBI probes Ackman and SXSW kicks off — 5 things to know today

By
March 13, 2015
Actavis CEO Brenton Saunders and Allergan CEO David Pyotton pose together on the floor of the New York Stock Exchange
Finance

Allergan CEO: How to survive an activist attack

By
February 12, 2015
Passive investors crushed the activists in 2014
Finance

Passive investors crushed the activists in 2014

By
January 9, 2015
Icahn Enterprises L.P. To Ring The NASDAQ Stock Market Closing Bell
Leadership

Why activist investors are getting even more…active

By
December 3, 2014
Activist investors: The best (and worst) performers of 2014
Finance

Activist investors: The best (and worst) performers of 2014

By
December 3, 2014
Actavis CEO Brenton Saunders and Allergan CEO David Pyotton pose together on the floor of the New York Stock Exchange
Finance

Allergan CEO hands Botox maker to lawyer instead of consultant

By
November 17, 2014
Botox
Finance

Actavis agrees to buy Botox-maker Allergan for $66 billion

By
November 17, 2014
Pershing Square's Bill Ackman and Valeant Pharmaceuticals International's Michael Pearson Interview
Finance

Zoetis shares spike on reported Ackman stake purchase

By
November 11, 2014
184366121
Leadership

Vote: Businessperson of the Year – Wall Street MVPs

By
November 11, 2014
Did Bill Ackman just kill the poison pill?
Finance

Did Bill Ackman just kill the poison pill?

By
November 6, 2014
Is Valeant the wrong partner for Bill Ackman’s bid for Allergan?

Is Valeant the wrong partner for Bill Ackman’s bid for Allergan?

By
October 30, 2014
Starbucks To Raise Prices On Select Drinks, And Lower On Simple Drinks
Features

Starbucks schedules and bitcoin on eBay — five things to know today

By
August 15, 2014
Finance
Finance

A look at how some of the top investors, hedge funds spent the second quarter

By
August 14, 2014
Botox
Finance

SEC is reportedly probing the Valeant-Ackman bid for Botox-maker Allergan

By
August 14, 2014

Most Popular